Open Access

Erratum to: A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids

  • Christian Vogelberg1Email author,
  • Petra Moroni-Zentgraf2,
  • Migle Leonaviciute-Klimantaviciene3,
  • Ralf Sigmund4,
  • Eckard Hamelmann5,
  • Michael Engel2 and
  • Stanley Szefler6
Respiratory Research201516:128

https://doi.org/10.1186/s12931-015-0290-7

Received: 12 October 2015

Accepted: 12 October 2015

Published: 20 October 2015

The original article was published in Respiratory Research 2015 16:20

Erratum

Following publication of our article [1] we identified an error in Fig. 5, where results were inadvertently switched between morning and evening PEF responses. The corrected Fig. 5 is provided in this erratum. The PEF results provided in our original article text remain correct.
Fig. 5

Morning and evening PEF response after 4 weeks of treatment (full analysis set). Adjusted for ‘treatment’, ‘period’, ‘patient’ and ‘baseline’. *p < 0.05 versus placebo Respimat®. PEF, peak expiratory flow

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
University Hospital Carl Gustav Carus, Technical University of Dresden
(2)
Boehringer Ingelheim Pharma GmbH & Co. KG
(3)
Vilnius University Hospital
(4)
Boehringer Ingelheim Pharma GmbH & Co. KG
(5)
Evangelisches Krankenhaus Bielefeld
(6)
Department of Pediatrics, Children’s Hospital of Colorado and the University of Colorado Denver School of Medicine

Reference

  1. Vogelberg C, Moroni-Zentgraf P, Leonaviciute-Klimantaviciene M, Sigmund R, Hamelmann E, Engel M, et al. A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids. Respir Res. 2015;16:20.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Vogelberg et al. 2015

Advertisement